Soligenix, Inc. (SNGX)

1.38 +0.01 (+0.73%) USD  |  NASDAQ  |  Jan 14, 16:00
1.405 +0.02 (+1.81%) Pre-Market: 08:52
More

Soligenix Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for SNGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Amgen, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Insmed, Inc. Upgrade
Tonix Pharmaceuticals Holding Corp. Upgrade
Citius Oncology, Inc. Upgrade